News Tag: 2022 newsletters
NRG Oncology PSC 2022 Winter Meeting Wrap Up
Read More
Congratulations to the NRG Oncology Members Assigned to NCI Gastrointestinal Task Forces – Rectal/Anal Cancers
Read More
FORTE Study Update – March NRG Newsletter
Read More
Coming Attractions or Recent Additions in NRG Colorectal Cancer Research: NRG-GI005
Read More
Coming Attractions or Recent Additions in NRG Colorectal Cancer Research: NRG-GI008
Read More
The NRG-GI004/SWOG1610, the COMMIT Study, may further improve outcomes in Metastatic Colorectal Cancer with deficiency of DNA repair (dMMR/MSI- H)
Read More
Dr. Miller Re-elected as Biostatistician for the NCI Uterine Task Force
Read More
RECIST 1.1 Criteria Toolkit: A Resource for Success in Clinical Trials with Solid Tumor Evaluation Requirements
Read More
NRG-CC008: A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Read More
FORTE Study Updates (Feb 2022 Newsletter)
Read More